Citadel Advisors »

Franklin Templeton Etf Tr genomic adv etf shares owned by Citadel Advisors

Quarter-by-quarter ownership of Franklin Templeton Etf Tr genomic adv etf (HELX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Franklin Templeton Etf Tr genomic adv etf

Tip: Access up to 7 years of quarterly data

All positions including Franklin Templeton Etf Tr genomic adv etf held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Franklin Templeton Etf Tr genomic adv etf by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $363k 11k 32.76

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Franklin Templeton Etf Tr genomic adv etf

Glenview Trust
Jane Street
Gts Securities
Citadel Advisors
LPL Financial
Commonwealth Equity Services
Susquehanna International
Advisor Group Holdings
Harbour Investments
Citigroup

View all funds holding Franklin Templeton Etf Tr genomic adv etf